The valuation paradox

Summary: Markets have looked “too expensive” for as long as most of us can remember, yet investors who waited for lower prices usually missed years of compounding. This piece explores why the idea of “expensive markets” is almost always with us, why fair value matters more than cheap value, and how disciplined stock selection—not timing—ultimately drives long-term returns. It also explains how a structured, research-backed approach helps investors stay invested with confidence even when valuations feel uncomfortable.

“The market is too expensive.” I’ve lost count of how many times I’ve heard this lament over the past three decades. Any number of talking heads and typing thumbs are constantly declaring with great certainty that valuations are at unsustainable levels, warning investors to stay away until prices become more ‘reasonable’. This chorus of caution has been remarkably persistent.

Here’s what strikes me most about these warnings: they’re almost always present. Scroll back through market commentary from any period since the mid-90s, and you’ll find the same concerns expressed with similar conviction. Except during actual market crashes and their immediate aftermath, when everything genuinely is cheap, but everyone is too terrified to buy, markets have perpetually appeared expensive to many observers.

The curious thing is, these concerns are often technically correct. If you compare current valuations to historical averages, markets frequently trade above their long-term norms. The P/E and P/B look elevated. From a statistical perspective, the caution appears justified.

Yet something interesting happens when we examine what actually happened to investors who waited for cheaper prices. More often than not, they missed out on significant wealth creation. The companies that seemed expensive at the time, the ones that made value-conscious investors uncomfortable, frequently turned out to be excellent investments when viewed with the benefit of hindsight.

Why does this pattern repeat itself so consistently? The answer lies in understanding the difference between expensive and fairly priced, a distinction that sounds simple but proves challenging to apply in practice.

A company trading at 25x earnings might seem expensive compared to one trading at 15x. However, if the first company is growing its profits rapidly with strong competitive advantages and minimal debt, while the second is growing more slowly and facing competitive pressures, the ‘expensive’ company is actually the bargain. The market isn’t being irrational. It’s pricing in the vast difference in business quality and future prospects.

This is why the investment principle I’ve come to value most is deceptively straightforward: choose carefully, buy fairly priced companies, then exercise patience. The emphasis on ‘fairly priced’ rather than ‘cheaply priced’ is deliberate. Cheap companies are often cheap for good reasons – deteriorating business models, poor management, structural challenges. Fair prices, on the other hand, reflect genuine business quality while still offering reasonable return prospects.

The challenge, of course, is identifying which companies are fairly priced and which are genuinely expensive. This requires rigorous analysis of business fundamentals, competitive positioning, management quality and growth prospects. You need to understand not just what a company has achieved historically but what it’s capable of achieving in the future. This demands time, expertise and access to comprehensive information resources most individual investors simply don’t possess.

I’ve watched countless investors struggle with this challenge. They understand that quality matters. They recognise that buying good companies makes more sense than chasing bargains. However, when faced with thousands of listed companies and a limited time to analyse them, they either become paralysed by choice or make decisions based on incomplete information.

This is precisely the problem we’ve structured Value Research Stock Advisor to solve. Rather than adding to the confusion with more stock recommendations, we’ve created three ready-made portfolios where the heavy lifting of distinguishing between fair and expensive valuations has already been done for you.

Our Long-term Growth Portfolio represents this philosophy in its purest form. Every company included has passed rigorous tests of business quality, competitive strength and management integrity. Some might appear expensive based on simple valuation metrics, but each has justified its valuation through consistent performance and clear growth runways. We’re not buying cheap companies hoping they’ll improve; we’re buying excellent companies at prices that offer return potential.

The Aggressive Growth Portfolio takes a similar approach but with a different time horizon. These companies might trade at valuations that seem even more stretched, but they’re building positions in emerging opportunities with significant long-term potential. History shows that when markets seem expensive overall, the highest-quality growth companies often provide the best long-term returns, even if their current valuations make cautious investors uncomfortable.

Our Dividend Growth Portfolio offers perhaps the clearest evidence of this principle at work. Many of these established, dividend-paying companies trade at what might seem like premium valuations. However, their ability to generate consistent cash flows that reward shareholders regularly and still grow their businesses justifies these prices. They’re not cheap, but they’re fairly priced given their quality and reliability.

What makes our approach valuable in today’s environment is its ongoing nature. Markets and companies evolve continuously. A fairly priced company today might become expensive tomorrow if its competitiveness falls or growth slows. Conversely, a company that seems expensive today may prove to be fairly priced as its business prospects strengthen.

Our research team constantly monitors all this, carrying out monthly reviews of every portfolio. When a company’s valuation moves from fair to expensive, or when better opportunities arise, we make the necessary changes and communicate them, so that you don’t spend your evenings analysing balance sheets or wondering if your stocks are overvalued.

This systematic approach tackles what I’ve seen as the biggest mistake individual investors make in seemingly expensive markets: either staying out and missing years of potential returns or chasing cheap-looking stocks that become poor investments. Both usually underperform a disciplined strategy of buying quality at fair prices and holding patiently.

The beauty of Stock Advisor’s portfolio structure is its simplicity. Choose the portfolio aligned with your goals, invest systematically and let our research guide you through changing market conditions. At Rs 9,990 a year, you gain access to professional-grade analysis that would be nearly impossible to replicate individually, no matter how much time you devoted to the task.

After three decades of market observation, I’ve realised that waiting for cheap markets is a losing strategy. Truly low prices appear only in crises, when most investors lack the courage to act. The winning approach is to find quality companies at fair valuations and then have the patience to let fundamentals drive long-term returns.

Markets may always look expensive. The real question is whether you have a method of distinguishing fair from expensive, and the discipline to act on it. That’s what Stock Advisor provides, and it’s why successful investing has less to do with market timing and everything to do with quality selection and patient execution.